Welcome

Investor Contact

Media & Investor Relations:
Troy Wichterman
Chief Financial Officer
(425) 402 - 1400
twichterman@biolifesolutions.com

Transfer Agent

Broadridge Corporate Issuer Solutions, Inc.
P.O. Box 1342
Brentwood, New York 11717
USA
(877) 830 - 4936
shareholder@broadridge.com

Investor Alerts

Investor Home

Investor Presentation

BioLife Solutions Investor Presentation October 2024

Recent Events

BioLife Solutions, Inc. Q3 2024 Earnings Conference Call and Business Update

Tuesday, November 12, 2024

1:30pm - 2:30pm PST

Latest News

Get News Alerts by Email

Dec 16, 2024

BioLife Solutions Appoints Tony J. Hunt to its Board of Directors

BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of bioproduction tools and services for the cell and gene therapy (CGT) market, announces the...

Nov 14, 2024

BioLife Solutions Announces $6.1 million Sale of its Custom Biogenic Systems Freezer Subsidiary

Completes the Company's strategic move away from capital equipment businesses BOTHELL, Wash., Nov. 14, 2024 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a...

View All News and Press Releases